Topline results from the Synuclein-One Study, presented at the American Academy of Neurology Annual Meeting in Boston April 22-27, were covered by several news outlets over the past two weeks.
The last two weeks brought important milestones for CND Life Sciences, and several news outlets are taking notice of major developments for the company.
WJAR news reported last month about a Pawtucket, Rhode Island man, Roger Miller, who began to suffer from shaky movements about 10 years ago.
Georgia Public Broadcasting featured a story this week about how the Syn-One Test helped Dr. Daniel Cobb, owner of The Neuro Center in Gainesville, Georgia, provide a diagnosis to Chris Griffin, a patient who was experiencing troubling and unexplained symptoms.
Dr. Toni De Marcaida, Medical Director of Hartford Healthcare’s Chase Family Movement Disorders Center in Hartford, CT, spoke this week on WFSB Channel 3 News about the positive impact the Syn-One Test has had on her practice and patients. “This is a test that has never been available to us as clinicians before.”
Todd Levine, MD, Chief Medical Officer and Co-Founder of CND Life Sciences was interviewed last month about the Syn-One Test® in a three-part series on the Lewy Body Roller Coaster podcast.
“It wasn’t until Robin’s autopsy that we got an accurate diagnosis,” explains Susan Schneider Williams, widow of the late comedian, in a talk she gave at Life Itself—a health and wellness conference presented in partnership with CNN.
Dr. Todd Levine, Chief Medical Officer and Co-Founder of CND Life Sciences will present as part of a Controversies in Movement Disorders panel discussion at 6:30 pm on May 23, 2022, in Punta Gorda, FL.
In honor of national Parkinson’s month, CN2 news in Rock Hill, SC featured Memory & Movement Charlotte, a medical practice focused on Parkinson’s disease and other neurological conditions, where Medical Director Dr. Sanjay Iyer has recently started offering the Syn-One Test to his patients.
Specialized neurologic and neurosurgical care center Marcus Neuroscience Institute, part of Baptist Health South Florida, is now offering its patients the Syn-One Test. Sameea Husain Wilson, D.O., director of Movement Disorder Neurology for the institute, cites the simplicity of administering the test, its high level of accuracy, and the speed with which patients get results as the major benefits of the test.